US 8754030
Defensin-antigen fusion proteins
granted A61KA61K31/7088A61K38/00
Quick answer
US patent 8754030 (Defensin-antigen fusion proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61K38/00, A61K38/19, A61K39/00117